Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 19.40% ...
PiperSandler analyst Joseph Catanzaro assigned a Buy rating to Gilead Sciences (GILD – Research Report) yesterday and set a price target of $105.00. The company’s shares opened today at $91.60.
Some results have been hidden because they may be inaccessible to you